Insider Transactions in Q4 2022 at Akoya Biosciences, Inc. (AKYA)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 22
2022
|
Joseph Driscoll Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250,000
+48.78%
|
$0
$0.44 P/Share
|
|
Dec 14
2022
|
Joseph Driscoll Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
24,613
-49.19%
|
$295,356
$12.57 P/Share
|
|
Dec 14
2022
|
Joseph Driscoll Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,613
+32.9%
|
$0
$0.44 P/Share
|
|
Dec 13
2022
|
Thomas P Schnettler Director |
SELL
Open market or private sale
|
Indirect |
71,050
-2.53%
|
$923,650
$13.03 P/Share
|
|
Dec 06
2022
|
Brian Mc Kelligon President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-5.88%
|
$60,000
$12.08 P/Share
|
|
Dec 06
2022
|
Brian Mc Kelligon President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+5.56%
|
$0
$0.3 P/Share
|
|
Dec 02
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
1,100
-0.19%
|
$14,300
$13.25 P/Share
|
|
Dec 01
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
5,000
-0.84%
|
$65,000
$13.36 P/Share
|
|
Nov 16
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
300
-0.05%
|
$3,900
$13.25 P/Share
|
|
Nov 14
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
600
-0.1%
|
$7,800
$13.28 P/Share
|
|
Nov 11
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
20,000
-3.23%
|
$260,000
$13.29 P/Share
|
|
Nov 10
2022
|
Garry Ph.D. Nolan Director |
SELL
Open market or private sale
|
Direct |
3,810
-0.61%
|
$49,530
$13.31 P/Share
|